Businesses involved in healthcare and pharmaceuticals can be tainted by compliance issues, beginning from the manufacture of a medical product up until the sale and export of these items.

  • Proper due diligence is ongoing and never static

    Proper due diligence is ongoing and never static

    Ongoing due diligence doesn’t only ensure that you’re on top of your partner’s compliance but also ensures that you’re meeting the ever-increasing regulatory demands.

    Read More
  • Meet your Healthcare requirements with our Due Diligence solutions

    Contact Us
  • Preparing for the California Consumer Privacy Act

    Preparing for the California Consumer Privacy Act

    Businesses are required to be CCPA-compliant or risk monetary liability or civil action. What actions do you need to prepare for compliance with the California Consumer Privacy Act?

    Read More
  • The missing piece of country intelligence gathering

    The missing piece of country intelligence gathering

    Compliance risks appear to be receiving much less coverage than they deserve in typical country intelligence offerings.

    Read More
  • How to nurture a culture of ethics

    How to nurture a culture of ethics

    Programmes that look good on paper may fall short if not put into action properly. A culture of ethics makes employees feel that acting ethically is the right thing to do.

    Read More
  • Database screening for third party compliance

    Database screening for third party compliance

    Companies have a number of choices when deciding how to quantify and deal with the compliance risks related to their partners. For higher-risk partners, active due diligence exercises...

    Read More
  • Questions about managing your Due Diligence Programme?

    Let us help
  • LATAM is catching up to improve healthcare regulations

    LATAM is catching up to improve healthcare regulations

    Although regulations in Latin America have lacked in the past, it is catching up in healthcare due to the growing demand for healthcare products, including pharmaceuticals.

    Read More
  • The Asian underworld: How criminals are enabled by legitimate businesses

    The Asian underworld: How criminals are enabled by legitimate businesses

    The infiltration of organised criminal groups into legitimate businesses has moved beyond the traditional underworld sectors into new industries such as renewable energy and pharmaceuticals.

    Read More
  • Companies and regulators aim to reduce costly investigation delays

    Companies and regulators aim to reduce costly investigation delays

    In July this year, the United States Department of Justice (DOJ) hired its first dedicated compliance specialist. The position sits in the DOJ’s Criminal Division, which prosecutes healthcare,...

    Read More
  • Asia Pacific | Old habits die hard

    Asia Pacific | Old habits die hard

    In the past two years, Japan has been through two major corporate scandals: one at Tokyo Electric Co (Tepco), and one at camera and medical-instrument maker Olympus. These two events clearly...

    Read More
  • Inside a world-class due diligence programme  with Becton, Dickinson and Company

    Inside a world-class due diligence programme with Becton, Dickinson and Company

    One company with a third party compliance and due diligence programme that has really stood out is Becton, Dickinson and Company (BD), the global medical device company based in New Jersey,...

    Read More
  • Improving user adoption and increasing global standardisation around third party risk management

    Improving user adoption and increasing global standardisation around third party risk management

    Since the client had plans to add more users and expand geographic focus, we helped them increase global standardisation around third party risk management.

    Read More
  • Enhancing global oversight of third parties

    Enhancing global oversight of third parties

    We created a more consistent risk-based approach across the global business owners and processes to enhance global oversight from the compliance department.

    Read More
  • Would you like receive exclusive updates?

    Subscribe
  • Medical device and pharma companies must go on the compliance offensive

    Medical device and pharma companies must go on the compliance offensive

    Medical device and pharmaceutical companies are under regulatory scrutiny like never before. Within the last five years, medical device manufacturers have been issued with 785 warning letters by ...

    Read More
  • China initiates drug pricing investigation

    China initiates drug pricing investigation

    The NDRC is one of the three antitrust law enforcement agencies in China, and its focus is on price-related monopoly activities.

    Read More
  • United States preventive rule raises the bar for food safety compliance

    United States preventive rule raises the bar for food safety compliance

    Such a policy has now been officially endorsed by the United States Food and Drug Administration (FDA), which has introduced a preventive controls rule for human food.

    Read More
  • Asia Pacific | India’s code of medical ethics regulations

    Asia Pacific | India’s code of medical ethics regulations

    One recent update which needs to be noticed by the industry is the Third Amendment (the Amendment) made to the Code of Medical Ethics Regulations by Medical Council of India (MCI) in December 2009.

    Read More
  • 2012 highlight review – the risks identified in leading industries

    2012 highlight review – the risks identified in leading industries

    Popular countries of research and investigation (Finanical Year 2012) The following is a summary of the countries in which The Red Flag Group conducted research and investigations in the 2012...

    Read More
  • Medical NGOs and Donations

    Medical NGOs and Donations

    Just because an entity describes themselves as an NGO does not necessarily mean that that they are an NGO or could be classified as a charity.

    Read More
  • China has made a major change to the way companies sell drugs and medical devices

    China has made a major change to the way companies sell drugs and medical devices

    The Chinese government has changed the way medical devices and drugs are sold to hospitals, clinics and state-sponsored medical offices.

    Read More
  • Which resources are required for a third party compliance programme?

    Which resources are required for a third party compliance programme?

    When The Red Flag Group is assisting companies to roll out third party compliance programmes, the firm is often asked which resources will be required to oversee and maintain those programmes...

    Read More
  • loading
    Loading More...